Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 2
2022 5
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Federated causal inference based on real-world observational data sources: application to a SARS-CoV-2 vaccine effectiveness assessment.
Meurisse M, Estupiñán-Romero F, González-Galindo J, Martínez-Lizaga N, Royo-Sierra S, Saldner S, Dolanski-Aghamanoukjan L, Degelsegger-Marquez A, Soiland-Reyes S, Van Goethem N, Bernal-Delgado E; BeYond-COVID project. Meurisse M, et al. BMC Med Res Methodol. 2023 Oct 23;23(1):248. doi: 10.1186/s12874-023-02068-3. BMC Med Res Methodol. 2023. PMID: 37872541 Free PMC article.
Homologous and Heterologous Prime-Boost Vaccination: Impact on Clinical Severity of SARS-CoV-2 Omicron Infection among Hospitalized COVID-19 Patients in Belgium.
Meurisse M, Catteau L, van Loenhout JAF, Braeye T, De Mot L, Serrien B, Blot K, Cauët E, Van Oyen H, Cuypers L, Belgian Collaborative Group On Covid-Hospital Surveillance, Covid-Genomics Belgium Consortium, Robert A, Van Goethem N. Meurisse M, et al. Vaccines (Basel). 2023 Feb 7;11(2):378. doi: 10.3390/vaccines11020378. Vaccines (Basel). 2023. PMID: 36851257 Free PMC article.
Clinical Severity of SARS-CoV-2 Omicron Variant Compared with Delta among Hospitalized COVID-19 Patients in Belgium during Autumn and Winter Season 2021-2022.
Van Goethem N, Chung PYJ, Meurisse M, Vandromme M, De Mot L, Brondeel R, Stouten V, Klamer S, Cuypers L, Braeye T, Catteau L, Nevejan L, van Loenhout JAF, Blot K. Van Goethem N, et al. Among authors: meurisse m. Viruses. 2022 Jun 14;14(6):1297. doi: 10.3390/v14061297. Viruses. 2022. PMID: 35746768 Free PMC article.
Association between COVID-19 Primary Vaccination and Severe Disease Caused by SARS-CoV-2 Delta Variant among Hospitalized Patients: A Belgian Retrospective Cohort Study.
Robalo Q, De Mot L, Vandromme M, Van Goethem N, Gabrio A, Chung PYJ, Meurisse M, Belgian Collaborative Group On Covid-Hospital Surveillance, Catteau L, Thijs C, Blot K. Robalo Q, et al. Among authors: meurisse m. Vaccines (Basel). 2022 Dec 21;11(1):14. doi: 10.3390/vaccines11010014. Vaccines (Basel). 2022. PMID: 36679859 Free PMC article.
One year of laboratory-based COVID-19 surveillance system in Belgium: main indicators and performance of the laboratories (March 2020-21).
Meurisse M, Lajot A, Dupont Y, Lesenfants M, Klamer S, Rebolledo J, Lernout T, Leroy M, Capron A, Van Bussel J, Quoilin S, Andre E, Kehoe K, Waumans L, Van Acker J, Vandenberg O, Van den Wijngaert S, Verdonck A, Cuypers L, Van Cauteren D. Meurisse M, et al. Arch Public Health. 2021 Oct 27;79(1):188. doi: 10.1186/s13690-021-00704-2. Arch Public Health. 2021. PMID: 34706768 Free PMC article.
Conceptual causal framework to assess the effect of SARS-CoV-2 variants on COVID-19 disease severity among hospitalized patients.
Van Goethem N, Serrien B, Vandromme M, Wyndham-Thomas C, Catteau L, Brondeel R, Klamer S, Meurisse M, Cuypers L, André E, Blot K, Van Oyen H. Van Goethem N, et al. Among authors: meurisse m. Arch Public Health. 2021 Oct 25;79(1):185. doi: 10.1186/s13690-021-00709-x. Arch Public Health. 2021. PMID: 34696806 Free PMC article.